Fingerprint
Dive into the research topics of 'Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies
Kian Huat Lim, Mateusz Opyrchal, Abhi Acharya, Nick Boice, Ningying Wu, Feng Gao, Jace Webster, Albert C. Lockhart, Saiama N. Waqar, Ramaswamy Govindan, Daniel Morgensztern, Joel Picus, Benjamin R. Tan, Maria Q. Baggstrom, Christopher A. Maher, Andrea Wang-Gillam
- Section of Medical Oncology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Division of Public Health Sciences
- Section of Molecular Oncology & Developmental Therapeutics
- Division of Oncology
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Molecular Cell Biology
- DBBS - Immunology
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations